SITOY GROUP (01023): Li Baoyu appointed as Chairman of the Compensation Committee.
Huarui Group Holdings (01023) announced that effective from the conclusion of the shareholders' annual meeting, Dr. Liu Jiancheng retired from his position as non-executive...
SITOY GROUP (01023) announced that, effective immediately after the conclusion of the shareholders' annual general meeting, Dr. Liu Jiancheng will retire as a non-executive director and will no longer be a member of the company's Environment, Social and Governance Committee. Mr. Long Hongzhao will retire as an independent non-executive director and will no longer serve as the chairman of the company's Remuneration Committee, as well as a member of the company's Audit Committee and Nomination Committee. Ms. Li Baoyu has been appointed as the chairman of the company's Remuneration Committee.
Related Articles

CF Pharmtech (02652) signs strategic cooperation with JD Health

HUTCHMED(00013) initiates Phase III clinical trial of HMPL-760 for the treatment of relapsed/refractory diffuse large B-cell lymphoma in China.
.png)
EVEREST MED (01952) enters into an asset purchase agreement with Jistar Pharmaceutical Hong Kong.
CF Pharmtech (02652) signs strategic cooperation with JD Health

HUTCHMED(00013) initiates Phase III clinical trial of HMPL-760 for the treatment of relapsed/refractory diffuse large B-cell lymphoma in China.

EVEREST MED (01952) enters into an asset purchase agreement with Jistar Pharmaceutical Hong Kong.
.png)
RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


